Cited by 27Lipid metabolism and disordersLipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Normolipemic dysbetalipoproteinemia and hyperlipoproteinemia type III in subjects homozygous for a rare genetic apolipoprotein E variant (apoE1).

Open access
Steinmetz, A, Assefbarkhi, N, Eltze, C, Ehlenz, K, Funke, H, Pies, A, Assmann, G, Kaffarnik, H·1990·Journal of Lipid Research

Abstract

A family with three heterozygote and two homozygote carriers of the rare apolipoprotein E1 isoform was detected by isoelectric focusing. One of the homozygous patients had type III hyperlipidemia, while the other showed normolipemic dysbetalipoproteinemia. Restriction fragment length analysis as well as allele specific oligonucleotides were used to identify the structural alterations forming the abnormal epsilon 1 genotype. Comparison with the most common epsilon 3 allele showed that two base exchanges A for G in codon 127 and T for G in codon 158 (Asp for Gly and Cys for Arg, respectively) are responsible for the amino acid substitution which causes the charge shift observed in isoelectric focusing. The same defects have been described in the only previously characterized apoE1 (Weisgraber et al. 1984. J. Clin. Invest. 73: 1024-1033). In addition to the study by Weisgraber and coworkers, who reported on a heterozygous patient, we here describe the metabolic and clinical consequences of a homozygosity for this rare allele. Changes in lipoprotein metabolism, as well as in clinical phenotypes, were exactly identical to those seen in patients homozygous for the epsilon 2 allele, which has in common with the epsilon 1 allele the mutation in codon 158, but lacks the substitution in codon 127. In addition, lipoprotein profiles of the epsilon 3/epsilon 1 heterozygotes were indistinguishable from those of epsilon 3/epsilon 2 heterozygotes. Therefore, we conclude that the additional m…

Integrity signals

Registry

Crossref · 10.1016/s0022-2275(20)42740-3

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The Gly127Asp variant is not causative of a dominantly inherited familial type III HLP and is not directly related to receptor binding, but may be one of the factors that cause hyperlipidemia in association with the ε2 allele.

    “This variant is not causative of a dominantly inherited familial type III HLP and is not directly related to receptor binding, but may be one of the factors that cause hyperlipidemia in association with the ε2 allele26, 58).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Steinmetz, A., Assefbarkhi, N., Eltze, C., Ehlenz, K., Funke, H., Pies, A., Assmann, G., & Kaffarnik, H.
Affiliations
Philipps University of Marburg (DE)
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
1990-06
Volume
31
Issue
6
Pages
1005-1013
ISSN
0022-2275 (ISSN-L)
OpenAlex
W2402186237
Cited by
27
References
7
Citations by year
2025: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2019: 1 · 2016: 1
FWCI
2.64
Type
journal article
Language
en
Open access
Locations
  • Journal of Lipid Research (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Keywords
apolipoprotein E isoforms, homozygosity, type III hyperlipoproteinemia, type III hyperlipidemia, amino acid substitutions, lipoprotein metabolism, genetic heterogeneity, familial hypercholesterolemia
MeSH terms
Adolescent, Adult, Apolipoproteins E, Base Sequence, DNA, Female, Humans, Hyperlipoproteinemia Type III, Lipoproteins, Male, Molecular Sequence Data, Polymorphism, Restriction Fragment Length, Oligonucleotide Probes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review